Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martin-Broto

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Medical Oncology|January 11, 2024
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in SpainJaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Nature Communications|October 21, 2022
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumorsJavier Martin-Broto, Andres Redondo, David S Moura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor eraPhilippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Investigational New Drugs|May 4, 2026
Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumorsAlejandro Falcón, Gregory M Cote, Javier Molina-Cerrillo, et al.
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2021
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European studyMahmoud Mohammadi, Nikki S IJzerman, Peter Hohenberger, et al.
Cancers|October 17, 2020
Prognostic Impact of <i>let-7e</i> MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|January 11, 2024
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in SpainJaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Nature Communications|October 21, 2022
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumorsJavier Martin-Broto, Andres Redondo, David S Moura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor eraPhilippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Future Oncology (London, England)|April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcomaMrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Investigational New Drugs|May 4, 2026
Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumorsAlejandro Falcón, Gregory M Cote, Javier Molina-Cerrillo, et al.
Signal Transduction and Targeted Therapy|October 24, 2023
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2AJavier Martin-Broto, Jeronimo Martinez-Garcia, David S Moura, et al.
The Oncologist|November 10, 2018
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)Javier Martin-Broto, Nadia Hindi, Josefina Cruz, et al.
Cancer|November 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trialEmanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2021
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European studyMahmoud Mohammadi, Nikki S IJzerman, Peter Hohenberger, et al.
Cancers|October 17, 2020
Prognostic Impact of <i>let-7e</i> MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) StudyAntonio Fernandez-Serra, David S Moura, María Dolores Sanchez-Izquierdo, et al.
Pageof 12